MOUNTAIN VIEW, Calif., Sept. 1 /PRNewswire-FirstCall/ -- VIVUS, Inc. (Nasdaq: VVUS), a pharmaceutical company dedicated to the development and commercialization of novel therapeutic products, today announced that Timothy Morris, Chief Financial Officer, will present an overview of the company at four healthcare investment conferences during the month of September.
The conference presentation schedule is as follows:
Rodman & Renshaw Annual Global Investment Conference September 10, 2009 at 10:50 a.m. ET The New York Palace Hotel, New York, NY Thomas Weisel Partners Healthcare Conference September 11, 2009 at 11:30 a.m. ET The Four Seasons Hotel, Boston, MA BioCentury's NewsMakers in the Biotech Industry Conference September 16, 2009 at 3:30 p.m. ET Millennium Broadway Hotel & Conference Center, New York, NY UBS Global Life Sciences Conference September 21, 2009 at 3:30 p.m. ET Grand Hyatt, New York, NY
A live audio webcast and 30-day archive of the presentations will be available on VIVUS' website at http://www.vivus.com.
VIVUS is a biopharmaceutical company developing innovative, next-generation therapies to address unmet needs in obesity, diabetes and sexual health. The company's lead product in clinical development, Qnexa(TM), is expected to complete phase 3 clinical trials for the treatment of obesity in 2009. Qnexa is also in phase 2 clinical development for the treatment of type 2 diabetes. In the area of sexual health, VIVUS is in phase 3 development with avanafil, a potentially best-in-class PDE5 inhibitor, and in phase 2 development of Luramist(TM) for the treatment of hypoactive sexual desire disorder (HSDD) in women. MUSE(R) (alprostadil), a first generation therapy for the treatment of ED, is already on the market and generating revenue for VIVUS. For more information about the company, please visit www.vivus.com.
CONTACT: Timothy E. Morris Chief Financial Officer VIVUS, Inc. +1-650-934-5200, Brian Korb Investor Relations The Trout Group, +1-646-378-2923 Sheryl Seapy Media Relations Pure Communications, Inc. +1-949-608-0841
|SOURCE VIVUS, Inc.|
Copyright©2009 PR Newswire.
All rights reserved